by Mark Angelides | Oct 2, 2021 | Articles, Good Reads, Healthcare, Opinion
Drug companies Merck and Ridgeback Biotherapeutics have announced the results of the latest round of tests on their oral COVID-19 pill. The data evidently shows a reduction in hospital stays and deaths for up to 50% of the trial participants. Emergency Use...